SLU-PP-332 (Research Compound) is a novel, non-stimulant investigational compound being studied for its potential to activate pathways associated with mitochondrial function, energy metabolism, and endurance performance.
SLU-PP-332 is a cutting-edge investigational compound being studied for its unique ability to activate estrogen-related receptors (ERRα, ERRβ, and ERRγ), which play a central role in regulating mitochondrial biogenesis, cellular energy production, and metabolic efficiency. Because of this mechanism, SLU-PP-332 is widely recognized in scientific research as an “exercise mimetic,” meaning it may replicate some of the molecular effects typically associated with endurance training.
Preclinical studies suggest that SLU-PP-332 may enhance fat oxidation, improve glucose utilization, support mitochondrial health, and increase endurance capacity without acting as a stimulant. These properties have made it an area of growing interest in research related to metabolic health, obesity, athletic performance, age-related decline, and neurodegenerative disorders.
Researchers are exploring SLU-PP-332 for its potential applications in:
SLU-PP-332 is intended strictly for laboratory and scientific research purposes. It is not approved by the U.S. Food and Drug Administration, Central Drugs Standard Control Organization, or any other regulatory authority for use in humans or animals, and it should not be used for diagnostic, therapeutic, or dietary purposes.
For Research Use Only. Not for Human Consumption.
High-quality research-grade peptides and compounds engineered for scientific innovation and laboratory use.